RECENT NEWS
January, 2012
A merger of Gardia Medical Ltd. (“Gardia”), a private company controlled by the venture capital funds group Medica Venture Partners, with Allium Medical Solutions Ltd. (“Allium”), in which all of the issued capital of Gardia was acquired. As part of the agreement, Allium shall invest at least US$ 3.5 million in the development of Gardia’s products, which regard to various solutions to emboli formed during catheterization.
November, 2011
Yuval Horn elected as an expert in Life Sciences by Who’s Who of Life Sciences Lawyers 2012.
October, 2011
Vision BI shareholders sell controlling interest to Keyrus, SA.
September 8, 2011
Completion of a merger of IBI Biomedical Innovations Ltd. (“IBI”) with Allium Medical Solutions Ltd. (“Allium”) in which all of the issued capital of IBI was acquired in consideration for 49.93% of the issued and paid up capital of Allium and its voting rights. In addition, Allium had allocated to IBI employees, consultants and officers non-negotiable option warrants.
August 22, 2011
Gefen Biomed Investments Ltd. files Shelf Prospectus with Israel Securities Authority.
May 22, 2011
Yuval Horn speaks at a dinner party for the French Delegation to the ILSI-BioMed 2011 Conference hosted by the Chamber of Commerce Israel – France.
May 9, 2011
Publication of the Israeli chapter by Yuval Horn, as the fifth edition of Anti-Corruption Regulation, a volume in the Getting the Deal Through series of annual reports, is published.
April 4, 2011
PicApp Inc. sells 100% of the share capital of PicApp Technologies Ltd. to Online Media Solutions Ltd., a wholly owned subsidiary of Ybrant Digital Limited.
March 6, 2011
Gefen Biomed Investments Ltd. enters into a joint venture, Horizon Ventures (A.G.R) Ltd., with Alstom Holdings S.A. and Rotem Industries Ltd., for investment in clean technology enterprises.
February 22, 2011
Yuval Horn publishes a new article: Funding and Opportunities of Life Science Companies – The Israeli Experience
February 9-11, 2011
Yuval Horn speaks at the IBA Israel Conference: The Global Commercialisation of Knowledge Based Industries
December, 2010
Collplant raises NIS 18.5 from the public on the Tel Aviv Stock Exchange
November, 2010
Gefen Biomed Investments raises NIS 7.5 from the public on the Tel Aviv Stock Exchange
November, 2010
Yuval Horn elected as Vice Chairman of the Life Sciences Committee of the International Bar Association
October 6, 2010
Yuval Horn speaks at the
IBA Annual Conference 3-8 October 2010
Vancouver Convention & Exhibition Centre West, Vancouver, Canada
Technology rights and distressed companies
August, 2010
Protalix Biotherapeutics Inc. approved for listing on the TASE, in addition to its current listing on the NYSE:AMEX.
Arineta Ltd. enters into a strategic collaboration agreement with GE.
June, 2010
Aposense Ltd. raises NIS 64 million in its IPO on TASE, and an additional sum of NIS 30 million in private offerings.
June 2, 2010
Israel Bar Association 10th Annual Conference in Eilat, Israel
Yuval Horn chairs the panel on Public Securities Market in Israel, featuring Prof. Oded Sarig, Prof. Amir Licht, Dr. Zvi Gabbay, Adv. Davida Lachman Messer.
May 25-26, 2010
IBA Technology Law Conference – The New Age of Health IT Radisson Blu Royal Hotel, Copenhagen, Denmark
David Eisen speaks about new developments in funding of technology companies
(IBA Technology Law Conference – The New Age of Health IT)
May 20, 2010
Collplant Ltd. completes its merger with Portfolio Green (TASE)
March, 2010
Biocancell Theraputics Inc. completes 2 PIPEs
February, 2010
Widemed Ltd. files a shelf registration statement with TASE